Clinical trial
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic…
NCT00295412 · Université de Montréal, Other · Completed
Key facts
| NCT number | NCT00295412 |
|---|---|
| Title | The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients |
| Official title | The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients |
| Lead sponsor | Université de Montréal, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Substance Use Disorders |
| Intervention type | Drug |
| Interventions | quetiapine (drug) |
| First posted | Feb 23, 2006 |
| Last update posted | Feb 23, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: